Filing Details
- Accession Number:
- 0001123292-20-001295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-23 17:50:59
- Reporting Period:
- 2020-12-21
- Accepted Time:
- 2020-12-23 17:50:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882104 | Pdl Biopharma Inc. | PDLI | Biological Products, (No Disgnostic Substances) (2836) | 943023969 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1029625 | A Edward Mule | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No | |
| 1332784 | L.p. Capital Point Silver | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No | |
| 1382617 | J Robert O'shea | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-21 | 230,000 | $2.63 | 15,491,460 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-12-22 | 850,000 | $2.59 | 16,341,460 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-12-23 | 485,000 | $2.60 | 16,826,460 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
